Guangzhou Wondfo Biotech Co., Ltd. founded in 1992 and headquartered in Guangzhou science city. Wondfo focuses on the R&D, manufacturing, sales and service of IVD industry, providing professional rapid diagnosis and chronic disease management solutions.
Wondfo has 9 technology platforms. Our rapid diagnostic devices and reagents span a wide spectrum, including cardiovascular diseases, diabetes, renal functions, respiratory issues, fertility, DOA, infections, tumors, etc. We provide services to over 150 countries and regions.
In 2015, Wondfo was listed on the Shenzhen Stock Exchange, becoming the first public company in POCT in China.
WonDx™ Automated Rapid Molecular Diagnostic System
WonDx™ Automated Rapid Molecular Diagnostic System redefine PCR with simplicity, efficiency, and precision.
This fully automated system integrates advanced microfluidics with magnetic bead-based nucleic acid extraction and real-time PCR, delivering sample-to-result qPCR analysis within 15 minutes.
The dual-amplification chamber design in cartridge, combined with the instrument’s 4 fluorescent channels, enables multiplex detection of seven targets per sample.
Throughput is scalable, supporting up to eight units for high-demand applications.
NE-9600 Nucleic Acid Extraction System
The analyzer is intended for the extraction and purification of nucleic acid from clinical samples.
Wondfo U-Card Dx™ Automated Rapid Molecular Diagnostic Instrument
Wondfo U-Card Dx™ Automated Rapid Molecular Diagnostic Instrument can rapidly deliver lab-quality results, with positive samples identified as soon as 28 minutes.
It is designed as a fully automated and fully enclosed instrument, thus minimizing manual handling and avoiding biosafety contamination, making it suitable for respiratory infections diagnosis in multi-scenes.
Monkeypox Virus Real-time PCR Assay
Wondfo Monkeypox Virus Real-Time PCR Assay is used for rapid, qualitative detection of monkeypox virus nucleic acid in whole blood, plasma, serum, scab and lesion exudate samples.
The test is to be used as an aid in the diagnosis of orthopox virus infection disease, which is caused by Monkeypox virus (MPV).
For in vitro diagnostic use only.
For professional use only.
U-Card Dx™ Monkeypox Virus Test
Wondfo U-Card Dx™ Monkeypox Virus Test is an automated, real-time polymerase chain reaction (PCR) assay intended for the rapid, in vitro qualitative detection of Monkeypox Virus in plasma, serum, scab and lesion exudate specimens.
The test is to be used as an aid in the diagnosis of orthopox virus infection disease, which is caused by Monkeypox Virus (MPV).
For in vitro diagnostic use only.
For professional use only.
U-Card Dx™ Monkeypox Virus Test
Wondfo U-Card Dx™ Monkeypox Virus Test is an automated, real-time polymerase chain reaction (PCR) assay intended for the rapid, in vitro qualitative detection of Monkeypox Virus in plasma, serum, scab and lesion exudate specimens.
The test is to be used as an aid in the diagnosis of orthopox virus infection disease, which is caused by Monkeypox Virus (MPV).
For in vitro diagnostic use only.
For professional use only.
U-Card Dx™ 2019-nCoV/Flu/RSV Test
The U-Card Dx™ 2019-nCoV/Flu/RSV Test is an automated, real-time reverse transcriptase polymerase chain reaction (Real time RT-PCR) assay intended for the rapid, in vitro qualitative detection of severe acute respiratory syndrome coronavirus 2 (2019-nCoV), influenza A (Flu A), influenza B (Flu B), and respiratory syncytial virus (RSV) viral RNA from nasopharyngeal (NP) swab or anterior nasal swab specimens.
The test is intended as an aid in the diagnosis of coronavirus infection disease (COVID-19) caused by 2019-nCoV and respiratory viral infections caused by Flu A, Flu B or RSV viruses.
2019-nCoV Real-Time RT-PCR Assay
Target genes are ORF1ab and N, designed in accordance with the diagnosis and treatment guideline issued by the National Health Commission.
Wondfo Viral Transport Medium
Wondfo Viral Transport Medium is suitable for collection, transport, maintenance and long-term freeze storage of clinical specimens, including chlamydia, mycoplasma or urea plasma organisms.
The transport medium comes in a plastic, screw cap tube and maintains organism viability for 48 hours at room or refrigerated temperature.
U-Card Dx™ 2019-nCoV/Flu/RSV Test
The U-Card Dx™ 2019-nCoV/Flu/RSV Test is an automated, real-time reverse transcriptase polymerase chain reaction (Real time RT-PCR) assay intended for the rapid, in vitro qualitative detection of:
-
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
Influenza A (Flu A)
-
Influenza B (Flu B)
-
Respiratory syncytial virus (RSV) viral RNA
from nasopharyngeal (NP) swab or anterior nasal swab specimens.
The test is intended as an aid in the diagnosis of:
-
Coronavirus infection disease (COVID-19) caused by 2019-nCoV
-
Respiratory viral infections caused by Flu A, Flu B, or RSV viruses
Wondfo 2019-nCoV/FluA/FluB PCR Assay
Wondfo 2019-nCoV/FluA/FluB PCR Assay is a real-time reverse transcription PCR (RT-PCR) assay for rapid, qualitative detection of:
-
2019-nCoV
-
Influenza A
-
Influenza B nucleic acid
in oropharyngeal swabs and nasopharyngeal swabs.
The test is intended to be used as an aid in the diagnosis of:
-
2019-nCoV infection
-
Influenza A infection
-
Influenza B infection
U-Card Dx™ 2019-nCoV Test
The U-Card Dx™ 2019-nCoV Test is an automated, real-time reverse transcriptase polymerase chain reaction (RT-PCR) assay intended for the rapid, in vitro qualitative detection of:
-
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) viral RNA
from nasopharyngeal (NP) swab samples.
The test is intended as an aid in the diagnosis of coronavirus infection disease (COVID-19) caused by 2019-nCoV.
U-Card Dx™ HPV Test
The U-Card Dx™ HPV Test is an automated, real-time polymerase chain reaction (PCR) assay intended for the rapid, in vitro qualitative detection of human papilloma virus (HPV) from cervical specimens.
The test is intended as an aid in the diagnosis of:
-
HPV infections: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
-
Genotypes 16 and 18 were specifically identified
For in vitro diagnostic use only. For professional use only.
Wondfo Nucleic Acid Extraction Kit
Wondfo Nucleic Acid Extraction Kit is used for extracting nucleic acid from non-cell/low cell content biological samples such as:
-
Whole blood
-
Fluid
-
Swab sample
-
Sputum
-
Bronchoalveolar lavage fluid
The extracted products can be used for clinical in vitro detection.
U-Card Dx™ CT/NG Test
The U-Card Dx™ CT/NG Test is an automated, real-time reverse transcriptase polymerase chain reaction (RT-real time PCR) assay intended for the rapid, in vitro qualitative detection of:
-
Chlamydia trachomatis (CT)
-
Neisseria gonorrhoeae (NG) DNA
from male or female urine, self-collected vaginal swab specimens, or clinician-collected endocervical or vaginal swab specimens.
The test is intended as an aid in the diagnosis of sexually transmitted disease (STD) infections caused by CT and NG pathogens.
U-Card Dx™ CT/NG/MG/TV Test
The U-Card Dx™ CT/NG/MG/TV Test is an automated, real-time reverse transcriptase polymerase chain reaction (RT-real time PCR) assay intended for the rapid, in vitro qualitative detection of:
-
Chlamydia trachomatis (CT)
-
Neisseria gonorrhoeae (NG)
-
Mycoplasma genitalium (MG)
-
Trichomonas vaginalis (TV) DNA
from male or female urine, self-collected vaginal swab specimens, or clinician-collected endocervical or vaginal swab specimens.
The test is intended as an aid in the diagnosis of sexually transmitted disease (STD) infections caused by CT, NG, MG, and TV pathogens.
U-Card Dx™ HPV16/18 Test
The U-Card Dx™ HPV16/18 Test is an automated, real-time polymerase chain reaction (PCR) assay intended for the rapid, in vitro qualitative detection of human papilloma virus (HPV) from cervical swab specimens.
The test is intended as an aid in the diagnosis of HPV16 and HPV18 infections caused by human papilloma virus.
U-Card Dx™ 2019-nCoV/Flu Test
The U-Card Dx™ 2019-nCoV/Flu Test is an automated, real-time reverse transcriptase polymerase chain reaction (RT-PCR) assay intended for the rapid, in vitro qualitative detection of:
-
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
Influenza A viral RNA
-
Influenza B viral RNA
from nasopharyngeal (NP) swab samples.
The test is intended as an aid in the diagnosis of:
-
Coronavirus infection disease (COVID-19) caused by 2019-nCoV
-
Influenza infections caused by Flu A or Flu B viruses